Aimmune Therap (AIMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2015 | 03-2015 | 12-2014 | 09-2014 | 06-2014 | |
Operating Expenses | 7,377 | 3,441 | 0 | 3,129 | 2,768 |
Operating Income | -7,377 | -3,441 | N/A | -3,129 | -2,768 |
Other Income | 1 | 0 | 0 | 0 | 5 |
Pre-tax Income | -7,376 | -3,441 | 0 | -3,129 | -2,763 |
Net Income Continuous | -7,376 | -3,441 | N/A | -3,129 | -2,763 |
Net Income | $-7,376 | $-3,441 | $N/A | $-3,129 | $-2,763 |
EPS Basic Total Ops | -1.60 | -0.81 | N/A | -1.07 | -0.94 |
EPS Basic Continuous Ops | -1.60 | -0.81 | N/A | -1.07 | -0.94 |
EPS Diluted Total Ops | -1.60 | -0.81 | N/A | -1.07 | -0.94 |
EPS Diluted Continuous Ops | -1.60 | -0.81 | N/A | -1.07 | -0.94 |
EBITDA(a) | $-7,358 | $-3,430 | $N/A | $-3,125 | $-2,768 |